| Literature DB >> 23493802 |
Mohammad Mehdi Heidari1, Mehri Khatami, Ali Reza Talebi.
Abstract
OBJECTIVES: Varicocele is associated with impaired testicular function and male infertility, but the molecular mechanisms by which fertility is affected have not been satisfactorily explained. The aim of our study was to investigate whether or not the polymerase gamma (POLG) polymorphism is associated with Iranian varicocele patients.Entities:
Keywords: CAG repeats length; Infertility; Mitochondria; POLG gene; Varicocele
Year: 2012 PMID: 23493802 PMCID: PMC3586882
Source DB: PubMed Journal: Iran J Basic Med Sci ISSN: 2008-3866 Impact factor: 2.699
Figure 1Genotyping of POLG CAG repeat by 8% denature polyacrylamide gel in patients. Lane 1, 4-6, 8 and 9: 10/10; lane 2 and 7: 10/11; lane 3: 10/12.
Distribution of semen quality in patients.
| Varicocele | Control (n=30) |
| ||||
|---|---|---|---|---|---|---|
| Variables | Grade I (n=15) | Grade II (n=13) | Grade III (n=12) | Overall (n=40) | ||
| Age | 34.50±5.82 | 30.55±5.03 | 26.63±5.99 | 31.58±6.16 | 31.26±5.31 | 0.8204 |
| Count (mil.ml-1) | 62.17±45.77 | 57.00±31.76 | 53.21±27.23 | 57.46±38.57 | 98.76±53.03 | 0.0003 |
| Rapid motility (%) | 17.51±9.41 | 13.48±7.94 | 12.78±5.21 | 14.59±7.57 | 23.24±10.05 | 0.0001 |
| Slow motility (%) | 36.17±9.90 | 40.64±11.78 | 32.53±10.20 | 36.44±10.93 | 33.45±7.16 | 0.1972 |
| Nonprogressive motility (%) | 11.41±5.40 | 12.92±3.11 | 13.10±3.67 | 12.47±3.99 | 10.98±3.69 | 0.1151 |
| Immotile motility (%) | 34.91±17.75 | 32.8±18.86 | 41.59±10.34 | 36.43±15.84 | 32.43±9.35 | 0.2228 |
| Normal morphology (%) | 28.08±12.98 | 18.09±12.07 | 23.68±7.35 | 23.63±11.66 | 44.52±14.46 | 0.0001 |
a: Difference between varicocele (n=40) and control (n=30) group
POLG genotype of varicocele patients and controls
| Allele (number of CAG repeats) | Num. of alleles in varicocele patients | Number of alleles in controls |
| ||||
|---|---|---|---|---|---|---|---|
| Grade I | Grade II | Grade III | Total | ||||
| 8 | 0 | 0 | 0 | 0 (0%) | 0 (0%) | - | |
| 9 | 1 | 3 | 1 | 5 (6.25%) | 3 (4.8%) | 0.7322 | |
| 10 | 29 | 21 | 14 | 62 (77.5%) | 54 (83.8%) | 0.6425 | |
| 11 | 2 | 2 | 7 | 11 (13.75%) | 4 (13%) | 0.2047 | |
| 12 | 0 | 0 | 2 | 2 (2.5%) | 0 (0%) | 0.2156 | |
| Genotype | Number of varicocele patients | Number of controls | |||||
| Grade I | Grade II | Grade III | Total | ||||
| 10/10 Homozygous | 12 | 8 | 3 | 23 (57.5%) | 21 (70%) | 0.6107 | |
| 10 /≠10 Heterozygous | 3 | 5 | 8 | 16 (40%) | 9 (30%) | 0.5497 | |
| ≠10/≠10 Homozygous + Heterozygous | 0 | 0 | 1 | 1 (2.5%) | 0 (0%) | 0.3890 | |
| Num. of samples | 15 | 13 | 12 | 40 | 30 | ||
a: Difference between varicocele and control group
Figure 2The Correlation between POLG genotype and Varicocele grade.